SML2868

Aclidinium bromide

≥98% (HPLC)

• Synonym(s): (3R)-(2-Hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide, (3R)-3-[(2-Hydroxy-2,2-di-2-thienylacetyl)oxy]-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide
• Empirical Formula (Hill Notation): C₂₆H₃₀BrNO₄S₂
• CAS Number: 320345-99-1
• Molecular Weight: 564.55
• UNSPSC Code: 12352200
• NACRES: NA.77
• Assay: ≥98% (HPLC)
• Form: powder

Properties

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• optical activity: [α]/D -24 to -30°, c = 0.1 in methanol
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: −20°C
• SMILES string: [s]1c(ccc1)C(O)(c5[s]ccc5)C(=O)O[C@@H]2C3CC[N+](C2)(CC3)CCCOc4ccccc4.[Br-]
• InChI: 1S/C26H30NO4S2.BrH/c28-25(26(29,23-9-4-17-32-23)24-10-5-18-33-24)31-22-19-27(14-11-20(22)12-15-27)13-6-16-30-21-7-2-1-3-8-21;/h1-5,7-10,17-18,20,22,29H,6,11-16,19H2;1H/q+1;/p-1/t20?,22-,27?;/m0./s1
• InChI key: XLAKJQPTOJHYDR-QTQXQZBYSA-M

Description

Biochem/physiol Actions

Aclidinium bromide is a long-acting muscarinic antagonist (LAMA) bronchodilator. It is a muscarinic M3, M2 antagonist with a long residence time at M3 receptors and a shorter residence time at M2 receptors. Aclidinium bromide was approved for the treatment of chronic obstructive pulmonary disease (COPD) in July 2012.

Long-acting muscarinic receptor antagonist; Bronchodilator.

Safety Information

• Storage Class: 11 - Combustible Solids
• wgk: WGK 3